|Articles|September 1, 2001
- Applied Clinical Trials-09-01-2001
Randomized Controlled Trials
New systems of ethical oversight for randomized controlled trials could ease the problems caused by increasingly cumbersome restrictions.
Advertisement
Articles in this issue
almost 25 years ago
Connecting at the Connectathonalmost 25 years ago
Patient Demands vs. Product Developmentalmost 25 years ago
EU Proposes Authorization Changesalmost 25 years ago
FDA Warning Lettersalmost 25 years ago
The Clinical Audit in Pharmaceutical Developmentalmost 25 years ago
What a Form 483 Really Meansalmost 25 years ago
Effective Invvestigator Meetingsalmost 25 years ago
A New Challange for Central Laboratoriesalmost 25 years ago
Domenico Criscuoloalmost 25 years ago
Monitoring Where Others Take HolidaysAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief: Execution Failures and Upstream Origins, European Data Governance Reshaping CROs, and Phase-Dependent Trial Competition
2
ACT Brief: Sponsor Oversight Capability Gaps, Community-Embedded Trial Partnerships, and Trialblazer Timeline Realism
3
Real-World Evidence in Transition: CRO Adaptation to the European Health Data Space Framework
4
The AI Churn Trap in Life Sciences and How to Break It
5